Download PDF
Semin Respir Crit Care Med 2005; 26(5): 527-540
DOI: 10.1055/s-2005-922036
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Lungs in Hemoglobinopathies, Erythrocyte Disorders, and Hemorrhagic Diatheses

Udaya B.S Prakash1
  • 1Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Rochester, Minnesota
Further Information

Publication History

Publication Date:
02 November 2005 (online)

    Permissions and Reprints

ABSTRACT

The erythropoietic system plays a major role in tissue oxygenation because the erythrocytes are the primary carriers of oxygen in the form of oxyhemoglobin. Therefore, clinical entities such as abnormal hemoglobins, polycythemia, anemia, and significant changes in blood volume frequently produce alterations in various respiratory functions. The pulmonary manifestations can vary from mild respiratory illness to life-threatening emergencies with high mortality rates. Among the hemoglobinopathies, sickle cell disease is clinically the most important and commonly associated with serious pulmonary consequences, including acute chest syndrome, pneumonia, infarction due to in situ thrombosis, bone marrow fat embolism of pulmonary vasculature, bone marrow infarction, pulmonary hypertension, and other abnormalities. Hemoglobinopathies with high and low affinity for oxygen and other abnormal hemoglobinopathies occasionally cause clinically significant respiratory complications by interfering with normal tissue oxygenation. Acquired methemoglobinemia can cause alarming cyanosis and medical emergency. Erythrocyte disorders are associated with pulmonary complications, including pulmonary hypertension, alveolar fibrosis, and pulmonary dysfunction. Coagulation disorders, both the inherited and acquired types, have the potential to affect the respiratory system in the form of hemorrhage from the airways, lung parenchyma, or pulmonary hypertension. The following paragraphs describe the common pulmonary complications and manifestations associated with hemoglobinopathies, erythrocyte disorders, and coagulation abnormalities.

KEYWORDS

Hemoglobinopathies - sickle cell disease - acute chest syndrome - thalassemia - coagulopathy - erythrocyte disorder - hemolytic anemia - stomatocytosis - methemoglobinemia - cyanosis - high-affinity hemoglobin - low-affinity hemoglobin - disseminated intravascular coagulation - paroxysmal nocturnal hemoglobinuria

REFERENCES

  • 1 Saunthararajah Y, Vichinsky E P, Embury S H. Sickle cell disease. In: Hoffman RH Hematology: Basic Principles and Practice. 4th ed. Philedelphia, PA; Elsevier 2005: 605-644
    Google Scholar
  • 2 Bonds D R. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype.  Blood Rev. 2005;  19 99-110
    CrossrefPubMedGoogle Scholar
  • 3 Bunn H F. Pathogenesis and treatment of sickle cell disease.  N Engl J Med. 1997;  337 762-769
    CrossrefPubMedGoogle Scholar
  • 4 Lane P A. Sickle cell disease.  Pediatr Clin North Am. 1996;  43 639-664
    CrossrefPubMedGoogle Scholar
  • 5 Stuart M J, Nagel R L. Sickle-cell disease.  Lancet. 2004;  364 1343-1360
    CrossrefPubMedGoogle Scholar
  • 6 Siddiqui A K, Ahmed S. Pulmonary manifestations of sickle cell disease.  Postgrad Med J. 2003;  79 384-390
    CrossrefPubMedGoogle Scholar
  • 7 Platt O S, Brambilla D J, Rosse W F et al.. Mortality in sickle cell disease: life expectancy and risk factors for early death.  N Engl J Med. 1994;  330 1639-1644
    CrossrefPubMedGoogle Scholar
  • 8 Vichinsky E P. Comprehensive care in sickle cell disease: its impact on morbidity and mortality.  Semin Hematol. 1991;  28 220-226
    PubMedGoogle Scholar
  • 9 Hebbel R P, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.  Microcirculation. 2004;  11 129-151
    CrossrefPubMedGoogle Scholar
  • 10 Hebbel R P, Vercellotti G M. The endothelial biology of sickle cell disease.  J Lab Clin Med. 1997;  129 288-293
    CrossrefPubMedGoogle Scholar
  • 11 Chien S, Usami S, Skalak R. Blood flow in small tubes. In: Renkin EM, Michel CC, Geiger SR Handbook of Physiology. Bethesda, MD; American Physiological Society 1993: 217-229
    Google Scholar
  • 12 Aquino S L, Gamsu G, Fahy J V et al.. Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT.  Radiology. 1994;  193 807-811
    PubMedGoogle Scholar
  • 13 Emre U, Miller S T, Rao S P, Rao M. Alveolar-arterial oxygen gradient in acute chest syndrome of sickle cell disease.  J Pediatr. 1993;  123 272-275
    PubMedGoogle Scholar
  • 14 Poncz M, Kane E, Gill F M. Acute chest syndrome in sickle cell disease: etiology and clinical correlates.  J Pediatr. 1985;  107 861-866
    PubMedGoogle Scholar
  • 15 Charache S, Scott J C, Charache P. “Acute chest syndrome” in adults with sickle cell anemia: microbiology, treatment, and prevention.  Arch Intern Med. 1979;  139 67-69
    CrossrefPubMedGoogle Scholar
  • 16 Castro O, Brambilla D J, Thorington B et al.. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.  Blood. 1994;  84 643-649
    PubMedGoogle Scholar
  • 17 Vichinsky E P, Neumayr L D, Earles A N et al.. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.  N Engl J Med. 2000;  342 1855-1865
    CrossrefPubMedGoogle Scholar
  • 18 Martin L, Buonomo C. Acute chest syndrome of sickle cell disease: radiographic and clinical analysis of 70 cases.  Pediatr Radiol. 1997;  27 637-641
    CrossrefPubMedGoogle Scholar
  • 19 Platt O S. The acute chest syndrome of sickle cell disease.  N Engl J Med. 2000;  342 1904-1907
    CrossrefPubMedGoogle Scholar
  • 20 Comber J T, Lopez B L. Evaluation of pulse oximetry in sickle cell anemia patients presenting to the emergency department in acute vasoocclusive crisis.  Am J Emerg Med. 1996;  14 16-18
    CrossrefPubMedGoogle Scholar
  • 21 Bellet P S, Kalinyak K A, Shukla R, Gelfand M J, Rucknagel D L. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases.  N Engl J Med. 1995;  333 699-703
    CrossrefPubMedGoogle Scholar
  • 22 Gelfand M J, Daya S A, Rucknagel D L, Kalinyak K A, Paltiel H J. Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome.  J Nucl Med. 1993;  34 614-618
    PubMedGoogle Scholar
  • 23 Babiker M A, Obeid H A, Ashong E F. Acute reversible pulmonary ischemia: a cause of the acute chest syndrome in sickle cell disease.  Clin Pediatr (Phila). 1985;  24 716-718
    PubMedGoogle Scholar
  • 24 Buchanan I D, Woodward M, Reed G W. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.  Pediatr Blood Cancer. 2005;  45 716-724
    CrossrefPubMedGoogle Scholar
  • 25 Rucknagel D L, Kalinyak K A, Gelfand M J. Rib infarcts and acute chest syndrome in sickle cell diseases.  Lancet. 1991;  337 831-833
    CrossrefPubMedGoogle Scholar
  • 26 Salzman S H. Does splinting from thoracic bone ischemia and infarction contribute to the acute chest syndrome in sickle cell disease?.  Chest. 2002;  122 6-9
    CrossrefPubMedGoogle Scholar
  • 27 Sprinkle R H, Cole T, Smith S, Buchanan G R. Acute chest syndrome in children with sickle cell disease: a retrospective analysis of 100 hospitalized cases.  Am J Pediatr Hematol Oncol. 1986;  8 105-110
    PubMedGoogle Scholar
  • 28 Bhalla M, Abboud M R, McLoud T C et al.. Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion.  Radiology. 1993;  187 45-49
    PubMedGoogle Scholar
  • 29 Walker B K, Ballas S K, Burka E R. The diagnosis of pulmonary thromboembolism in sickle cell disease.  Am J Hematol. 1979;  7 219-232
    PubMedGoogle Scholar
  • 30 Kaur N, Motwani B, Sivasubramaniam D et al.. Potential role of the ventilation and perfusion (V/Q) lung scan in the diagnosis of acute chest syndrome in adults with sickle cell disease.  Am J Hematol. 2004;  77 407-409
    CrossrefPubMedGoogle Scholar
  • 31 Feldman L, Gross R, Garon J et al.. Sickle cell patient with an acute chest syndrome and a negative chest x-ray: potential role of the ventilation and perfusion (V/Q) lung scan.  Am J Hematol. 2003;  74 214-215
    CrossrefPubMedGoogle Scholar
  • 32 Noto H. Hemoglobin SC disease presenting as acute chest syndrome with ventilation-perfusion mismatches.  Respiration. 1999;  66 73-77
    CrossrefPubMedGoogle Scholar
  • 33 Pearson H A, Spencer R P, Cornelius E A. Functional asplenia in sickle-cell anemia.  N Engl J Med. 1969;  281 923-926
    PubMedGoogle Scholar
  • 34 Winkelstein J A, Drachman R H. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.  N Engl J Med. 1968;  279 459-466
    PubMedGoogle Scholar
  • 35 Winkelstein J A. Pneumococcal infections in sickle cell disease.  J Pediatr. 1977;  91 521-522
    PubMedGoogle Scholar
  • 36 Greene J R, Polk O D, Castro O. Fulminant pneumococcal sepsis in an adult with sickle-cell anemia.  N Engl J Med. 1984;  311 674
    PubMedGoogle Scholar
  • 37 Olopoenia L, Frederick W, Greaves W, Adams R, Addo F E, Castro O. Pneumococcal sepsis and meningitis in adults with sickle cell disease.  South Med J. 1990;  83 1002-1004
    PubMedGoogle Scholar
  • 38 Barrett-Connor E. Bacterial infection and sickle cell anemia: an analysis of 250 infections in 166 patients and a review of the literature.  Medicine (Baltimore). 1971;  50 97-112
    PubMedGoogle Scholar
  • 39 Zarkowsky H S, Gallagher D, Gill F M et al.. Bacteremia in sickle hemoglobinopathies.  J Pediatr. 1986;  109 579-585
    PubMedGoogle Scholar
  • 40 Dagan R, Melamed R, Zamir O, Leroy O. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.  Pediatr Infect Dis J. 1997;  16 1053-1059
    CrossrefPubMedGoogle Scholar
  • 41 Wong W Y, Powars D R, Chan L, Hiti A, Johnson C, Overturf G. Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience.  Am J Hematol. 1992;  39 176-182
    PubMedGoogle Scholar
  • 42 Falletta J M, Woods G M, Verter J I et al.. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.  J Pediatr. 1995;  127 685-690
    PubMedGoogle Scholar
  • 43 Gaston M H, Verter J I, Woods G et al.. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial.  N Engl J Med. 1986;  314 1593-1599
    PubMedGoogle Scholar
  • 44 Hongeng S, Wilimas J A, Harris S, Day S W, Wang W C. Recurrent Streptococcus pneumoniae sepsis in children with sickle cell disease.  J Pediatr. 1997;  130 814-816
    PubMedGoogle Scholar
  • 45 Wang W C, Wong W Y, Rogers Z R, Wilimas J A, Buchanan G R, Powars D R. Antibiotic-resistant pneumococcal infection in children with sickle cell disease in the United States.  J Pediatr Hematol Oncol. 1996;  18 140-144
    CrossrefPubMedGoogle Scholar
  • 46 Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality.  Pediatrics. 1988;  81 749-755
    PubMedGoogle Scholar
  • 47 Ward J, Smith A L. Hemophilus influenzae bacteremia in children with sickle cell disease.  J Pediatr. 1976;  88 261-263
    PubMedGoogle Scholar
  • 48 Marcinak J F, Frank A L, Labotka R L et al.. Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in 3- to 17-month-old infants with sickle cell diseases.  J Pediatr. 1991;  118 69-71
    PubMedGoogle Scholar
  • 49 Miller S T, Hammerschlag M R, Chirgwin K et al.. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease.  J Pediatr. 1991;  118 30-33
    PubMedGoogle Scholar
  • 50 Kirkpatrick M B, Haynes Jr J, Bass Jr J B. Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome.  Am J Med. 1991;  90 206-210
    PubMedGoogle Scholar
  • 51 Bowman S J. Pulmonary tuberculosis precipitating the nephrotic syndrome in a patient with sickle cell disease.  Nephron. 1991;  57 236
    PubMedGoogle Scholar
  • 52 Ryan T J, O'Connor T F, Mc C P, Katz S. Sickle cell trait and tuberculosis.  Am Rev Respir Dis. 1960;  81 546-549
    PubMedGoogle Scholar
  • 53 Chan O, Loveday E. Case report: widespread tuberculosis in sickle cell disease.  Clin Radiol. 1992;  45 211-214
    CrossrefPubMedGoogle Scholar
  • 54 Lowenthal E A, Wells A, Emanuel P D, Player R, Prchal J T. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review.  Am J Hematol. 1996;  51 207-213
    CrossrefPubMedGoogle Scholar
  • 55 Saarinen U M, Chorba T L, Tattersall P et al.. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia.  Blood. 1986;  67 1411-1417
    PubMedGoogle Scholar
  • 56 Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection.  Semin Hematol. 1988;  25 159-172
    PubMedGoogle Scholar
  • 57 Vichinsky E, Williams R, Das M et al.. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia.  Blood. 1994;  83 3107-3112
    CrossrefPubMedGoogle Scholar
  • 58 Godeau B, Schaeffer A, Bachir D et al.. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism.  Am J Respir Crit Care Med. 1996;  153 1691-1696
    PubMedGoogle Scholar
  • 59 Vichinsky E, Styles L. Pulmonary complications.  Hematol Oncol Clin North Am. 1996;  10 1275-1287
    CrossrefPubMedGoogle Scholar
  • 60 Williams R A. Lipid-laden alveolar macrophages may indicate either aspiration pneumonia or sickle cell acute chest syndrome associated with pulmonary fat embolism.  Arch Pathol Lab Med. 1995;  119 772
    PubMedGoogle Scholar
  • 61 Barrett-Connor E. Acute pulmonary disease and sickle cell anemia.  Am Rev Respir Dis. 1971;  104 159-165
    PubMedGoogle Scholar
  • 62 Charache S, Lubin B, Reid C. Management and Therapy of Sickle Cell Disease. NIH publication no. 89-2117. Washington, DC; National Institutes of Health 1989
    Google Scholar
  • 63 Gillett D S, Gunning K E, Sawicka E H, Bellingham A J, Ware R J. Life threatening sickle chest syndrome treated with extracorporeal membrane oxygenation.  Br Med J (Clin Res Ed). 1987;  294 81-82
    PubMedGoogle Scholar
  • 64 Godeau B, Dhainaut J F, Bachir D, Galacteros F. Pulmonary fat embolism after prostaglandin infusion in sickle cell disease with fatal outcome despite exchange blood transfusion.  Am J Hematol. 1993;  43 330-331
    PubMedGoogle Scholar
  • 65 Bargoma E M, Mitsuyoshi J K, Larkin S K, Styles L A, Kuypers F A, Test S T. Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome.  Blood. 2005;  105 3384-3385
    CrossrefPubMedGoogle Scholar
  • 66 Kuypers F A, Styles L A. The role of secretory phospholipase A2 in acute chest syndrome.  Cell Mol Biol (Noisy-le-grand). 2004;  50 87-94
    PubMedGoogle Scholar
  • 67 Styles L A, Schalkwijk C G, Aarsman A J, Vichinsky E P, Lubin B H, Kuypers F A. Phospholipase A2 levels in acute chest syndrome of sickle cell disease.  Blood. 1996;  87 2573-2578
    PubMedGoogle Scholar
  • 68 Styles L A, Aarsman A J, Vichinsky E P, Kuypers F A. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease.  Blood. 2000;  96 3276-3278
    PubMedGoogle Scholar
  • 69 Ataga K I, Sood N, De Gent G et al.. Pulmonary hypertension in sickle cell disease.  Am J Med. 2004;  117 665-669
    CrossrefPubMedGoogle Scholar
  • 70 Castro O, Hoque M, Brown B D. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival.  Blood. 2003;  101 1257-1261
    CrossrefPubMedGoogle Scholar
  • 71 Castro O. Systemic fat embolism and pulmonary hypertension in sickle cell disease.  Hematol Oncol Clin North Am. 1996;  10 1289-1303
    CrossrefPubMedGoogle Scholar
  • 72 Powars D, Weidman J A, Odom-Maryon T, Niland J C, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.  Medicine (Baltimore). 1988;  67 66-76
    PubMedGoogle Scholar
  • 73 Haque A K, Gokhale S, Rampy B A, Adegboyega P, Duarte A, Saldana M J. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases.  Hum Pathol. 2002;  33 1037-1043
    CrossrefPubMedGoogle Scholar
  • 74 Gladwin M T, Sachdev V, Jison M L et al.. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.  N Engl J Med. 2004;  350 886-895
    CrossrefPubMedGoogle Scholar
  • 75 Lin E E, Rodgers G P, Gladwin M T. Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.  Curr Hematol Rep. 2005;  4 117-125
    PubMedGoogle Scholar
  • 76 Machado R F, Gladwin M T. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.  Br J Haematol. 2005;  129 449-464
    CrossrefPubMedGoogle Scholar
  • 77 Morris C R, Morris Jr S M, Hagar W et al.. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?.  Am J Respir Crit Care Med. 2003;  168 63-69
    CrossrefPubMedGoogle Scholar
  • 78 Hammond T G, Mosesson M W. Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease.  Arch Intern Med. 1989;  149 447-448
    CrossrefPubMedGoogle Scholar
  • 79 Haupt H M, Moore G W, Bauer T W, Hutchins G M. The lung in sickle cell disease.  Chest. 1982;  81 332-337
    PubMedGoogle Scholar
  • 80 Oppenheimer E H, Esterly J R. Pulmonary changes in sickle cell disease.  Am Rev Respir Dis. 1971;  103 858-859
    PubMedGoogle Scholar
  • 81 Rahimtoola S, Good C J, Davies P D. Pulmonary infarction in disorders associated with the sickle cell trait.  Thorax. 1960;  15 320-324
    PubMedGoogle Scholar
  • 82 Israel R H, Salipante J S. Pulmonary infarction in sickle cell trait.  Am J Med. 1979;  66 867-869
    CrossrefPubMedGoogle Scholar
  • 83 Karayalcin G, Imran M, Rosner F. “Blister cells”: association with pregnancy, sickle cell disease, and pulmonary infarction.  JAMA. 1972;  219 1727-1729
    CrossrefPubMedGoogle Scholar
  • 84 Maggi J C, Nussbaum E. Massive pulmonary infarction in sickle cell anemia.  Pediatr Emerg Care. 1987;  3 30-32
    PubMedGoogle Scholar
  • 85 Sugarman J, Samuelson W M, Wilkinson Jr R H, Rosse W F. Pulmonary embolism and splenic infarction in a patient with sickle cell trait.  Am J Hematol. 1990;  33 279-281
    PubMedGoogle Scholar
  • 86 Eckardt P, Raez L E, Restrepo A, Temple J D. Pulmonary bone marrow embolism in sickle cell disease.  South Med J. 1999;  92 245-247
    CrossrefPubMedGoogle Scholar
  • 87 Girard W. Case report: postoperative pulmonary edema and sickle cell crisis.  Clin Notes Respir Dis. 1979;  17 13-14
    PubMedGoogle Scholar
  • 88 Haynes Jr J, Allison R C. Pulmonary edema: complication in the management of sickle cell pain crisis.  Am J Med. 1986;  80 833-840
    CrossrefPubMedGoogle Scholar
  • 89 Wall M A, Platt O S, Strieder D J. Lung function in children with sickle cell anemia.  Am Rev Respir Dis. 1979;  120 210-214
    PubMedGoogle Scholar
  • 90 Collins F S, Orringer E P. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies.  Am J Med. 1982;  73 814-821
    CrossrefPubMedGoogle Scholar
  • 91 Leong M A, Dampier C, Varlotta L, Allen J L. Airway hyperreactivity in children with sickle cell disease.  J Pediatr. 1997;  131 278-283
    PubMedGoogle Scholar
  • 92 Bryant R. Asthma in the pediatric sickle cell patient with acute chest syndrome.  J Pediatr Health Care. 2005;  19 157-162
    CrossrefPubMedGoogle Scholar
  • 93 Knight-Madden J M, Forrester T S, Lewis N A, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome.  Thorax. 2005;  60 206-210
    CrossrefPubMedGoogle Scholar
  • 94 Nordness M E, Lynn J, Zacharisen M C, Scott P J, Kelly K J. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease.  Clin Mol Allergy. 2005;  3 2
    CrossrefPubMedGoogle Scholar
  • 95 Samuels M P, Stebbens V A, Davies S C, Picton-Jones E, Southall D P. Sleep-related upper airway obstruction and hypoxaemia in sickle cell disease.  Arch Dis Child. 1992;  67 925-929
    PubMedGoogle Scholar
  • 96 Davies S C, Stebbens V A, Samuels M P, Southall D P. Upper airways obstruction and cerebrovascular accident in children with sickle cell anaemia.  Lancet. 1989;  2 283-284
    PubMedGoogle Scholar
  • 97 Sidman J D, Fry T L. Exacerbation of sickle cell disease by obstructive sleep apnea.  Arch Otolaryngol Head Neck Surg. 1988;  114 916-917
    PubMedGoogle Scholar
  • 98 Miller G J, Serjeant G R, Saunders M J, Richardson C, Gilson R J. Interpretation of lung function tests in the sickle-cell haemoglobinopathies.  Thorax. 1978;  33 85-88
    PubMedGoogle Scholar
  • 99 Santoli F, Zerah F, Vasile N, Bachir D, Galacteros F, Atlan G. Pulmonary function in sickle cell disease with or without acute chest syndrome.  Eur Respir J. 1998;  12 1124-1129
    CrossrefPubMedGoogle Scholar
  • 100 Hijazi Z, Onadeko B O, Khadadah M, Haider M Z, Adekile A D, Al-Habashi H. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.  Int J Clin Pract. 2005;  59 163-167
    CrossrefPubMedGoogle Scholar
  • 101 Sylvester K P, Patey R A, Milligan P et al.. Pulmonary function abnormalities in children with sickle cell disease.  Thorax. 2004;  59 67-70
    PubMedGoogle Scholar
  • 102 Pianosi P, D'Souza S J, Charge T D, Esseltine D E, Coates A L. Pulmonary function abnormalities in childhood sickle cell disease.  J Pediatr. 1993;  122 366-371
    PubMedGoogle Scholar
  • 103 Femi-Pearse D, Gazioglu K M, Yu P N. Pulmonary function studies in sickle cell disease.  J Appl Physiol. 1970;  28 574-577
    PubMedGoogle Scholar
  • 104 Villa M P, Rotili P L, Santamaria F et al.. Physical performance in patients with thalassemia before and after transfusion.  Pediatr Pulmonol. 1996;  21 367-372
    CrossrefPubMedGoogle Scholar
  • 105 Youngchaiyud P, Suthamsmai T, Fucharoen S, Udompanich V, Pushpakom R, Wasi P. Lung function tests in splenectomized beta-thalassemia/Hb E patients.  Birth Defects Orig Artic Ser. 1987;  23 361-370
    PubMedGoogle Scholar
  • 106 Santamaria F, Villa M P, Ronchetti R. Pulmonary function abnormalities in thalassemia major.  Am J Respir Crit Care Med. 1995;  151 919
    PubMedGoogle Scholar
  • 107 Piatti G, Allegra L, Ambrosetti U, Cappellini M D, Turati F, Fiorelli G. Beta-thalassemia and pulmonary function.  Haematologica. 1999;  84 804-808
    PubMedGoogle Scholar
  • 108 Keens T G, O'Neal M H, Ortega J A, Hyman C B, Platzker A C. Pulmonary function abnormalities in thalassemia patients on a hypertransfusion program.  Pediatrics. 1980;  65 1013-1017
    PubMedGoogle Scholar
  • 109 Hoyt R W, Scarpa N, Wilmott R W, Cohen A, Schwartz E. Pulmonary function abnormalities in homozygous beta-thalassemia.  J Pediatr. 1986;  109 452-455
    PubMedGoogle Scholar
  • 110 Ooi G C, Khong P L, Chan G C et al.. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients.  Br J Haematol. 2004;  124 385-390
    CrossrefPubMedGoogle Scholar
  • 111 Grisaru D, Rachmilewitz E A, Mosseri M et al.. Cardiopulmonary assessment in beta-thalassemia major.  Chest. 1990;  98 1138-1142
    PubMedGoogle Scholar
  • 112 Factor J M, Pottipati S R, Rappoport I, Rosner I K, Lesser M L, Giardina P J. Pulmonary function abnormalities in thalassemia major and the role of iron overload.  Am J Respir Crit Care Med. 1994;  149 1570-1574
    PubMedGoogle Scholar
  • 113 Cooper D M, Hyman C B, Weiler-Ravell D, Noble N A, Agness C L, Wasserman K. Gas exchange during exercise in children with thalassemia major and Diamond-Blackfan anemia.  Pediatr Res. 1985;  19 1215-1219
    PubMedGoogle Scholar
  • 114 Freedman M H, Grisaru D, Olivieri N, MacLusky I, Thorner P S. Pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine infusions.  Am J Dis Child. 1990;  144 565-569
    PubMedGoogle Scholar
  • 115 Gallant T, Freedman M H, Vellend H, Francombe W H. Yersinia sepsis in patients with iron overload treated with deferoxamine.  N Engl J Med. 1986;  314 1643
    PubMedGoogle Scholar
  • 116 Fucharoen S, Youngchaiyud P, Wasi P. Hypoxaemia and the effect of aspirin in thalassaemia.  Southeast Asian J Trop Med Public Health. 1981;  12 90-93
    PubMedGoogle Scholar
  • 117 Rostagno C, Prisco D, Abbate R, Poggesi L. Pulmonary hypertension associated with long-standing thrombocytosis.  Chest. 1991;  99 1303-1305
    PubMedGoogle Scholar
  • 118 Eldor A, Durst R, Hy-Am E et al.. A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood.  Br J Haematol. 1999;  107 739-746
    CrossrefPubMedGoogle Scholar
  • 119 Cappellini M D, Robbiolo L, Bottasso B M, Coppola R, Fiorelli G, Mannucci A P. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.  Br J Haematol. 2000;  111 467-473
    CrossrefPubMedGoogle Scholar
  • 120 Percy M J, McFerran N V, Lappin T R. Disorders of oxidised haemoglobin.  Blood Rev. 2005;  10 61-68
    PubMedGoogle Scholar
  • 121 Dinneen S F, Mohr D N, Fairbanks V F. Methemoglobinemia from topically applied anesthetic spray.  Mayo Clin Proc. 1994;  69 886-888
    PubMedGoogle Scholar
  • 122 Rosen P J, Johnson C, McGehee W G, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia: association with glucose-6-phosphate dehydrogenase deficiency.  Ann Intern Med. 1971;  75 83-86
    CrossrefPubMedGoogle Scholar
  • 123 Bogdan C J, Strauss M, Ratnoff O D. Airway obstruction in hemophilia (factor VIII deficiency): a 28-year institutional review.  Laryngoscope. 1994;  104 789-794
    PubMedGoogle Scholar
  • 124 Schulman S, Johnsson H, Blomqvist S. Pulmonary hypertension in hemophilia.  Ann Intern Med. 1988;  109 759-760
    PubMedGoogle Scholar
  • 125 Goldsmith Jr G H, Baily R G, Brettler D B et al.. Primary pulmonary hypertension in patients with classic hemophilia.  Ann Intern Med. 1988;  108 797-799
    PubMedGoogle Scholar
  • 126 Takeda R, Mabuchi H. A massive pulmonary hemorrhage resulting in cavitation occurring in a case of hemophilia A associated with diabetes mellitus.  South Med J. 1974;  67 869-873
    PubMedGoogle Scholar
  • 127 Robboy S J, Minna J D, Colman R W, Birndorf N I, Lopas H. Pulmonary hemorrhage syndrome as a manifestation of disseminated intravascular coagulation: analysis of ten cases.  Chest. 1973;  63 718-721
    PubMedGoogle Scholar
  • 128 Thomson F J, Benbow E W, McMahon R F, Cheshire C M. Pulmonary infarction, myocardial infarction, and acute disseminated intravascular coagulation.  J Clin Pathol. 1991;  44 1034-1036
    PubMedGoogle Scholar
  • 129 Katsumura Y, Ohtsubo K. Incidence of pulmonary thromboembolism, infarction and haemorrhage in disseminated intravascular coagulation: a necroscopic analysis.  Thorax. 1995;  50 160-164
    PubMedGoogle Scholar
  • 130 Stahl R L, Javid J P, Lackner H. Unrecognized pulmonary embolism presenting as disseminated intravascular coagulation.  Am J Med. 1984;  76 772-778
    CrossrefPubMedGoogle Scholar
  • 131 Pesola G R, Carlon G C. Pulmonary embolus-induced disseminated intravascular coagulation.  Crit Care Med. 1987;  15 983-984
    PubMedGoogle Scholar
  • 132 Jubelirer S J. Primary pulmonary hypertension: its association with microangiopathic hemolytic anemia and thrombocytopenia.  Arch Intern Med. 1991;  151 1221-1223
    CrossrefPubMedGoogle Scholar
  • 133 Stuard I D, Heusinkveld R S, Moss A J. Microangiopathic hemolytic anemia and thrombocytopenia in primary pulmonary hypertension.  N Engl J Med. 1972;  287 869-870
    PubMedGoogle Scholar
  • 134 Mustafa M H, Mispireta L A, Pierce L E. Occult pulmonary embolism presenting with thrombocytopenia and elevated fibrin split products.  Am J Med. 1989;  86 490-491
    CrossrefPubMedGoogle Scholar
  • 135 Warkentin T E. Pseudo-heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A Heparin-Induced Thrombocytopenia. 3rd ed. New York; Marcel Dekker 2004: 313
    Google Scholar
  • 136 Warkentin T E, Levine M N, Hirsh J et al.. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.  N Engl J Med. 1995;  332 1330-1335
    CrossrefPubMedGoogle Scholar
  • 137 Badmanaban B, Sachithanandan A, Hunter I, Graham A, Sarsam M. Massive pulmonary embolism due to late-onset heparin-induced thrombocytopenia following coronary artery bypass graft surgery: successful treatment with lepirudin.  J Card Surg. 2003;  18 316-318
    CrossrefPubMedGoogle Scholar
  • 138 Betrosian A P, Theodossiades G, Lambroulis G et al.. Heparin-induced thrombocytopenia with pulmonary embolism and disseminated intravascular coagulation associated with low-molecular-weight heparin.  Am J Med Sci. 2003;  325 45-47
    PubMedGoogle Scholar
  • 139 Tefferi A, Solberg L A, Silverstein M N. A clinical update in polycythemia vera and essential thrombocythemia.  Am J Med. 2000;  109 141-149
    CrossrefPubMedGoogle Scholar
  • 140 Berlin N I. Polycythemia vera: diagnosis and treatment 2002.  Expert Rev Anticancer Ther. 2002;  2 330-336
    CrossrefPubMedGoogle Scholar
  • 141 Nand S, Orfei E. Pulmonary hypertension in polycythemia vera.  Am J Hematol. 1994;  47 242-244
    PubMedGoogle Scholar
  • 142 Ruggeri M, Tosetto A, Castaman G, Rodeghiero F. Pulmonary embolism after pregnancy in a patient with polycythemia vera.  Am J Hematol. 2001;  67 216-217
    CrossrefPubMedGoogle Scholar
  • 143 Scharenberg C, Riera R, Gorg C, Walthers E M, Barth P J. Thrombotic pulmonary arteriopathy in polycythemia vera.  Pathol Res Pract. 1999;  195 653-656
    PubMedGoogle Scholar
  • 144 Ishihara S, Yasuhara H, Ogawa S, Muto T. Successful surgical treatment for spontaneous retroperitoneal hematoma in polycythemia vera: report of a case.  Surg Today. 2000;  30 199-201
    CrossrefPubMedGoogle Scholar
  • 145 Dingli D, Utz J P, Krowka M J, Oberg A L, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders.  Chest. 2001;  120 801-808
    CrossrefPubMedGoogle Scholar
  • 146 Marvin K S, Spellberg R D. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia.  Chest. 1993;  103 642-644
    PubMedGoogle Scholar
  • 147 Murata M, Kuroda T, Nakajima K, Fujikawa H, Shimada K. Primary pulmonary hypertension with severe systemic hypertension, Raynaud's phenomenon and relative polycythemia.  Intern Med. 2001;  40 905-910
    PubMedGoogle Scholar
  • 148 Burgess J H, Bishop J M. Pulmonary diffusing capacity and its subdivisions in polycythemia vera.  J Clin Invest. 1963;  42 997-1006
    PubMedGoogle Scholar
  • 149 Herbert S J, Weill H, Stuckey W J, Urner C, Gonzales E, Ziskind M M. Pulmonary diffusing capacity in polycythemic states before and after phlebotomy.  Dis Chest. 1965;  48 408-415
    PubMedGoogle Scholar
  • 150 Cruz J C, Diaz C, Marticorena E, Hilario V. Phlebotomy improves pulmonary gas exchange in chronic mountain polycythemia.  Respiration. 1979;  38 305-313
    PubMedGoogle Scholar
  • 151 Dinakara P, Blumenthal W S, Johnston R F, Kauffman L A, Solnick P B. The effect of anemia on pulmonary diffusing capacity with derivation of a correction equation.  Am Rev Respir Dis. 1970;  102 965-969
    PubMedGoogle Scholar
  • 152 Heller P G, Grinberg A R, Lencioni M, Molina M M, Roncoroni A J. Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria.  Chest. 1992;  102 642-643
    PubMedGoogle Scholar
  • 153 Scadding J W. Fibrosing alveolitis with autoimmune haemolytic anaemia: two case reports.  Thorax. 1977;  32 134-139
    PubMedGoogle Scholar
  • 154 Jison M L, Gladwin M T. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.  Am J Respir Crit Care Med. 2003;  168 3-4
    CrossrefPubMedGoogle Scholar
  • 155 Perel Y, Dhermy D, Carrere A et al.. Portal vein thrombosis after splenectomy for hereditary stomatocytosis in childhood.  Eur J Pediatr. 1999;  158 628-630
    CrossrefPubMedGoogle Scholar
  • 156 Stewart G W, Amess J A, Eber S W et al.. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis.  Br J Haematol. 1996;  93 303-310
    CrossrefPubMedGoogle Scholar

Udaya B.S PrakashM.D. 

Department of Pulmonary and Critical Care Medicine, East-18, Mayo Bldg., Mayo Medical Center, Rochester, MN 55905

Email: prakash.udaya@mayo.edu

      >